Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Novo Nordisk A/SEli Lilly And CoAstraZenecaAbbott LaboratoriesBristol-Myers Squibb
SymbolNYSE:NVONYSE:LLYNYSE:AZNNYSE:ABTNYSE:BMY
Price Information
Current Price$66.36$163.87$53.80$92.23$59.14
52 Week RangeHoldBuyHoldBuyBuy
Beat the Market™ Rank
Overall Score2.02.11.62.32.2
Analysis Score4.12.43.02.32.4
Community Score2.22.71.92.72.6
Dividend Score2.53.31.74.24.2
Ownership Score0.01.00.01.01.0
Earnings & Valuation Score1.31.31.31.30.6
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuyBuy
Consensus Price Target$236.00$169.73$61.67$100.27$68.17
% Upside from Price Target255.64% upside3.57% upside14.62% upside8.71% upside15.26% upside
Trade Information
Market Cap$156.26 billion$156.73 billion$141.19 billion$163.14 billion$133.82 billion
Beta0.450.260.550.970.73
Average Volume1,441,1334,349,9555,668,3606,009,59516,725,952
Sales & Book Value
Annual Revenue$18.30 billion$22.32 billion$24.38 billion$31.90 billion$26.15 billion
Price / Sales8.547.025.795.115.12
Cashflow$2.83 per share$7.08 per share$3.17 per share$4.99 per share$4.39 per share
Price / Cash23.4923.1416.9918.4813.47
Book Value$3.65 per share$2.81 per share$5.56 per share$17.70 per share$23.20 per share
Price / Book18.1858.329.685.212.55
Profitability
Net Income$5.84 billion$8.32 billion$1.34 billion$3.69 billion$3.44 billion
EPS$2.46$6.04$1.75$3.24$4.69
Trailing P/E Ratio26.0227.0991.1946.3573.01
Forward P/E Ratio21.7620.7720.6125.348.02
P/E Growth$2.39$1.52$1.60$3.81$1.14
Net Margins31.91%23.97%5.94%11.15%3.08%
Return on Equity (ROE)73.87%194.18%33.97%18.61%30.06%
Return on Assets (ROA)32.56%15.11%7.88%8.61%10.96%
Dividend
Annual Payout$1.12$2.96$1.86$1.44$1.80
Dividend Yield1.69%1.81%3.46%1.56%3.04%
Three-Year Dividend GrowthN/AN/AN/A93.94%90.70%
Payout Ratio45.53%49.01%106.29%44.44%38.38%
Years of Consecutive Dividend Growth1 Years5 YearsN/A47 Years10 Years
Debt
Debt-to-Equity Ratio0.05%4.37%1.32%0.55%0.86%
Current Ratio1.00%1.11%0.75%1.43%1.66%
Quick Ratio0.73%0.86%0.57%1.01%1.51%
Ownership Information
Institutional Ownership Percentage6.69%77.44%16.84%73.64%74.17%
Insider Ownership Percentage0.07%0.09%N/A1.70%0.14%
Miscellaneous
Employees43,25833,62564,400107,00030,000
Shares Outstanding2.35 billion956.45 million2.62 billion1.77 billion2.26 billion
Next Earnings Date8/14/2020 (Estimated)7/30/2020 (Confirmed)7/30/2020 (Confirmed)7/16/2020 (Confirmed)8/6/2020 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.